TipRanks Cyber Monday Sale
- Claim 60% off TipRanks Premium for data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
Heart Test Laboratories, Inc. ( (HSCS) ) has provided an update.
Heart Test Laboratories, Inc. announced that it filed an Offering Statement on Form 1-A with the SEC, which was qualified on March 10, 2025, to offer up to 4,285,714 units at $3.50 per unit, aiming to raise $15 million. As of July 16, 2025, the company has raised $2.8 million through several closings, issuing 797,452 units. Holders of 486,815 shares of Series D Preferred Stock have converted their shares into common stock, contributing to a total of 1,797,914 shares of common stock issued and outstanding.
The most recent analyst rating on (HSCS) stock is a Buy with a $12.00 price target. To see the full list of analyst forecasts on Heart Test Laboratories, Inc. stock, see the HSCS Stock Forecast page.
Spark’s Take on HSCS Stock
According to Spark, TipRanks’ AI Analyst, HSCS is a Neutral.
The overall score is primarily influenced by the company’s significant financial challenges, which are a major risk factor. However, the stock’s technical momentum and the recent strategic patent grant provide some positive offsetting factors. The lack of earnings call data limits further insights into company guidance and sentiment.
To see Spark’s full report on HSCS stock, click here.
More about Heart Test Laboratories, Inc.
Average Trading Volume: 76,693
Technical Sentiment Signal: Sell
Current Market Cap: $4.24M
For a thorough assessment of HSCS stock, go to TipRanks’ Stock Analysis page.